Loading...
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Subunit vaccines have been investigated in over 1000 clinical trials of cancer immunotherapy, but have shown limited efficacy. Nanovaccines may improve efficacy but have rarely been clinically translated. By conjugating molecular vaccines with Evans blue (EB) into albumin-binding vaccines (AlbiVax),...
Na minha lista:
Udgivet i: | Nat Commun |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Nature Publishing Group UK
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5715147/ https://ncbi.nlm.nih.gov/pubmed/29203865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-02191-y |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|